Less than half of individuals with depression experience a positive response to their initial prescribed medication. Additionally, with each unsuccessful medication attempt, treatment intolerance tends to escalate.
It may be beneficial to consider offering the Gene Matrix test to the following groups:
- New patients who have previously encountered medication failures.
- Patients who are currently facing a lower-than-desired response to medication.
- Patients who are currently experiencing undesirable side effects.
- Elderly patients.
- Patients with liver damage.
By providing the Gene Matrix test to these individuals, you can potentially enhance treatment outcomes and minimize the challenges associated with medication trials.